Xvivo Perfusion AB (publ) (0RKL.L)

SEK 461.69

(1.25%)

Gross Profit Summary of Xvivo Perfusion AB (publ)

  • Xvivo Perfusion AB (publ)'s latest annual gross profit in 2023 was 416.91 Million SEK , up 40.4% from previous year.
  • Xvivo Perfusion AB (publ)'s latest quarterly gross profit in 2024 Q2 was 158.24 Million SEK , up 17.13% from previous quarter.
  • Xvivo Perfusion AB (publ) reported a annual gross profit of 296.95 Million SEK in annual gross profit 2022, up 57.72% from previous year.
  • Xvivo Perfusion AB (publ) reported a annual gross profit of 188.27 Million SEK in annual gross profit 2021, up 41.59% from previous year.
  • Xvivo Perfusion AB (publ) reported a quarterly gross profit of 135.1 Million SEK for 2024 Q1, up 53.57% from previous quarter.
  • Xvivo Perfusion AB (publ) reported a quarterly gross profit of 158.24 Million SEK for 2024 Q2, up 17.13% from previous quarter.

Annual Gross Profit Chart of Xvivo Perfusion AB (publ) (2023 - 2012)

Historical Annual Gross Profit of Xvivo Perfusion AB (publ) (2023 - 2012)

Year Gross Profit Gross Profit Growth
2023 416.91 Million SEK 40.4%
2022 296.95 Million SEK 57.72%
2021 188.27 Million SEK 41.59%
2020 132.97 Million SEK -18.33%
2019 162.81 Million SEK 19.76%
2018 135.95 Million SEK 19.89%
2017 113.39 Million SEK 10.92%
2016 102.23 Million SEK 20.33%
2015 84.96 Million SEK 32.65%
2014 64.04 Million SEK 18.3%
2013 54.13 Million SEK 374.39%
2012 11.41 Million SEK 0.0%

Peer Gross Profit Comparison of Xvivo Perfusion AB (publ)

Name Gross Profit Gross Profit Difference